Aptissen S.A. is a Swiss company specialized in the development and commercialization of biopolymer-based medical devices. Aptissen’s founders have developed for the past 25 years the best quality injectable products which meet both patients and doctors expectations.
The company was founded in 2013 as a spin-off of ANTEIS, and is based in Geneva area, Switzerland. It today distributes its products through a worldwide international distributors’ network among more than 50 countries including Europe, South America, Canada, Middle East and Asia for instance.
Aptissen’s team revolutionized the viscosupplement market with Synolis VA and his patented formulation which combines Hyaluronic Acid and Sorbitol. Synolis VA provides rapid mobility recovery, fast long lasting pain relief associated with excellent safety: www.synolis.com
By 2018, half-million of joints were treated with Aptissen’s products. We place the patient benefit at the center of our mission to develop innovative injectable solutions based on hyaluronic acid that can be combined with other molecules. We plan to bring a clinically proven global approach, including oral or topical forms.